診療所における舌下免疫療法の検討

Abstract

Background: Allergen immunotherapy is the only curative treatment for allergic rhinitis (AR) that can induce long-term clinical remission. In Japan, sublingual immunotherapy (SLIT) is often employed for the treatment of AR caused by Japanese cedar pollen (JCP) and house dust mites (HDM). To obtain a high likelihood for remission, SLIT should be continued for at least 3 to 5 years; however, a substantial number of patients dropout from the treatment.